Physician profile
Lucy Sun
NPI 1235215286
$1,913.46
in general payments reported to CMS, 2019-2025
9 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.13 · 2020: $12.26 · 2021: $346 · 2022: $566 · 2023: $198 · 2024: $512 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,027.16 | 2021-2025 | Venaseal |
| Boston Scientific Corporation | $324.16 | 2022-2025 | Varithena Administration Pack |
| Biotronik INC. | $144.05 | 2021 | |
| Tactile Systems Technology INC | $131.84 | 2019-2025 | Flexitouch Plus, Nimbl |
| Philips North America LLC | $128.45 | 2021 | |
| Cardiovascular Systems INC. | $87.74 | 2022 | |
| Bard Peripheral Vascular, INC. | $29.76 | 2022 | |
| Nevro Corp. | $20.97 | 2024 | Senza |
| Resmed Corp | $19.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.